Patient Partnerships: Challenges and Opportunities for Pharma with Durhane Wong-Rieger, President & CEO of the Canadian Organization for Rare Disorders

Durhane Wong-Rieger, President & CEO of the Canadian Organization for Rare Disorders, joins Natalie Yeadon, Co-Founder & CEO at Impetus Digital. We explore how to best involve patients in all aspects of the drug lifecycle, innovative approaches to drug access and financing, and other topics related to rare disease treatment and advocacy.To find out more about Impetus: https://www.meetwithimpetus.comNatalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/Impetus Digital Website: https://www.impetusdigital.com/Impetus Digital LinkedIn: https://www.linkedin.com/company/impetus-digital/Impetus Digital Twitter: https://twitter.com/impetus_digitalImpetus YouTube: https://www.youtube.com/ImpetusDigitalDurhane Wong-Rieger: https://www.linkedin.com/in/durhane-wong-rieger-5851b39/Canadian Organization for Rare Disorders: http://www.raredisorders.ca/Impetus Digital has been delivering best-in-class virtual and hybrid meetings, events, and programs for global life science companies since 2008. We work closely with clinical, market access, medical affairs, marketing, medical education, and many other departments to virtualize their internal and external stakeholder meetings, such as advisory boards, learning programs, working groups, and congress engagement initiatives. We partner with clients at all stages of the product life cycle, from R&D to loss of exclusivity.Click the social media buttons to share this episode with your network!To learn more about Impetus, our services, and our tools: https://www.meetwithimpetus.comNatalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/Impetus Digital Website: Home PageLinkedIn: https://www.linkedin.com/company/impetus-digital/Twitter: impetus_digitalYouTube: Impetus Digital